SHARLEEN BOTERO: Open Payments
NPI 1932862679 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 52 payments from 16 companies in 2025. Trend: 2023 $703 · 2024 $1,050 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $423 |
| Lilly USA, LLC | 7 | $122 |
| Bausch Health US, LLC | 4 | $77 |
| Dexcom, Inc. | 3 | $72 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Hologic Sales and Service, LLC | 1 | $34 |
| Exact Sciences Corporation | 2 | $31 |
| Dynavax Technologies Corporation | 2 | $24 |
Products named: Ozempic, Wegovy, MOUNJARO, APLENZIN, Dexcom G6 Transmitter, SHINGRIX, NUZYRA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
